nomela®
Melanoma risk-assessment technology
Non-invasive screening aid to indicate the chance of melanoma in pigmented skin lesions (moles)
On-device AI by machine-learning
Single-application iPads
For use by medical professionals
Intended positioning: the clinical pathway for the management of suspect skin lesions
Applies automated edge detection to exclude surrounding skin
Cyber Security Plus certified
QMS ISO 13485 certified
The nomela® test
nomela® features
Support
Fully integrated infrastructure with easy input to electronic patient records (EPR). Connectivity, device delivery, updates, replacements
and 24-hour help-line.
Process flows
Easy integration of nomela® reports into electronic patient records. Standalone infrastructure for surveillance of diagnosis and location and regional overview of activity via real-time dashboard.